Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP235199.RAeo0NS_jMUzg-nIGSyc5EP8ezX0J7DnNB2_XVaz-xdao130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP235199.RAeo0NS_jMUzg-nIGSyc5EP8ezX0J7DnNB2_XVaz-xdao130_assertion type Assertion NP235199.RAeo0NS_jMUzg-nIGSyc5EP8ezX0J7DnNB2_XVaz-xdao130_head.
- NP235199.RAeo0NS_jMUzg-nIGSyc5EP8ezX0J7DnNB2_XVaz-xdao130_assertion wasGeneratedBy ECO_0000203 NP235199.RAeo0NS_jMUzg-nIGSyc5EP8ezX0J7DnNB2_XVaz-xdao130_provenance.
- NP235199.RAeo0NS_jMUzg-nIGSyc5EP8ezX0J7DnNB2_XVaz-xdao130_assertion wasDerivedFrom befree-20140225 NP235199.RAeo0NS_jMUzg-nIGSyc5EP8ezX0J7DnNB2_XVaz-xdao130_provenance.
- NP235199.RAeo0NS_jMUzg-nIGSyc5EP8ezX0J7DnNB2_XVaz-xdao130_assertion SIO_000772 11061491 NP235199.RAeo0NS_jMUzg-nIGSyc5EP8ezX0J7DnNB2_XVaz-xdao130_provenance.
- NP235199.RAeo0NS_jMUzg-nIGSyc5EP8ezX0J7DnNB2_XVaz-xdao130_assertion evidence source_evidence_literature NP235199.RAeo0NS_jMUzg-nIGSyc5EP8ezX0J7DnNB2_XVaz-xdao130_provenance.
- NP235199.RAeo0NS_jMUzg-nIGSyc5EP8ezX0J7DnNB2_XVaz-xdao130_assertion description "[The presence of these SST receptor subtypes in human ovarian cancers allows the use of SST analogs and their radionuclide and cytotoxic derivatives for the diagnosis and treatment of this malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP235199.RAeo0NS_jMUzg-nIGSyc5EP8ezX0J7DnNB2_XVaz-xdao130_provenance.